Carvedilol
Status | Commercial |
Development phase | |
Therapeutic cat. | Cardiology |
Polymorphic form | Form II |
CAS No. | 72956-09-3 |
Reference Product | |
Injectable Form | |
EU DMF readiness | |
CEP | |
CHINESE DMF | |
JAPANESE DMF | |
KOREAN DMF | |
CANADIAN DMF | |
CADIFA | |
US DMF readiness | |
OEB No. | |
Samples |
Drug description
Carvedilol is a beta-blocker. Beta-blockers affect the heart and circulation (blood flow through arteries and veins). Carvedilol is used to treat heart failure and hypertension (high blood pressure). It is also used after a heart attack that has caused your heart not to pump as well. Carvedilol may also be used for purposes not listed in this medication guide.
Polpharma API
- Long experience in in-house commercial manufacturing
- Tailor-made PSD
- Secure and high-quality intermediate sources
Disclaimer
Products protected by patents (SPC) in Poland are developed solely for the purpose of Regulatory Submissions or R&D purposes intended to support Regulatory Submissions. These products are not offered for sale or made available in countries where such products are subject to patent (SPC) protection and where the offer for sale or any related activity constitutes patent infringement. It is within the buyer’s responsibility and liability to check the patent situation of the product in the import market(s).